Affymax, Inc. Share Price Nasdaq
Equities
US00826A1097
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2012 | 94.37M 7.46B | Sales 2013 | 1.37M 108M | Capitalization | 29.24M 2.31B |
---|---|---|---|---|---|
Net income 2012 | -93M -7.36B | Net income 2013 | -14M -1.11B | EV / Sales 2012 | 6.75 x |
Net cash position 2012 | 69.14M 5.47B | Net cash position 2013 | 5.6M 443M | EV / Sales 2013 | 17.3 x |
P/E ratio 2012 |
-7.39
x | P/E ratio 2013 |
-2.03
x | Employees | - |
Yield 2012 * |
-
| Yield 2013 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.65% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |